Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 249
YÖKSİS249 OpenAlex0
Projects 24
Books 23
Proceedings 497

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 185
h-index 21 Percentile in Türkiye: 98 Without large collaborations: h 20 · 1 papers #73 of 2,177 at their university by h-index
i10-index
49
Total citations
2,040
Top 1.6% in Türkiye
Per article
11.0
FWCI
1.77
1.00 = world average
World top 1%
4
World top 10%
21

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 197
  • Q1 71 %35.5
  • Q2 52 %26.0
  • Q3 57 %28.5
  • Q4 20 %10.0
WoS (JCR) 190
  • Q1 50 %26.0
  • Q2 33 %17.2
  • Q3 45 %23.4
  • Q4 64 %33.3
TR Index 41 articles
OpenAlex citation percentile
Top 1%4
Top 10%41
Avg · n 365 %56.5
Other counts

Scopus (SJR)

  • Excluding abstracts 195 Q1 69 Q2 52 Q3 57 Q4 20
  • Best Q 197 Q1 71 Q2 51 Q3 56 Q4 19
  • YÖKSİS rows 399

WoS (JCR)

  • Excluding abstracts 188 Q1 48 Q2 33 Q3 45 Q4 64
  • Best Q 190 Q1 50 Q2 33 Q3 45 Q4 62
  • YÖKSİS rows 381

TR Index

  • YÖKSİS rows 76 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

249articles

Journals with publications

126 journals

Showing the first 80 journals (126 in total).

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article filter applied. Journal filter: Cancer Investigation Clear filter ×

Article list

3 / 249 articles

  1. 2025 Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer Cancer Investigation DOI 10.1080/07357907.2025.2598042 YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.8%
  2. 2024 Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms Cancer Investigation DOI 10.1080/07357907.2024.2330102 4 YÖKSİS records YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.0%
  3. 2017 Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study Cancer Investigation DOI 10.1080/07357907.2017.1292518 3 YÖKSİS records YÖKSİS SJR Q2 JCR Q4 OpenAlex 5.1%

← Back to academicians